Biotricity, Inc. stock is down -12.81% since 30 days ago. The next earnings date is Feb 13, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 37.5% of the previous 7 December’s closed higher than November. 0% of analysts rate it a buy.
Biotricity, Inc. provides biometric data monitoring solutions primarily in the United States. Company offers Bioflux mobile cardiac telemetry solution, an integrated electrocardiogram (ECG) device and software solution.